The molecular diagnostic approach for infectious disease such as STDs, tropical, and respiratory disease has seen significant development in the past twelve months, driven by a demand for better, faster, higher sensitivity assays, that can detect asymptomatic carriers. Traditionally, lab-based tests using blood samples have been the mainstay for molecular testing, however home-based, extraction-free tests, using alternative sample types (saliva, urine, stool) are now highly sought after, but pose significant challenges in assay development for both lab-based and point of care (POC) applications.
In this webinar you will learn about:
- New nucleic acid amplification chemistries that simplify direct detection
- Optimizing assay performance per sample types (e.g. blood, saliva, urine, stool)
- The latest technologies that can reduce your cold-chain management
Michele Amasio, Ph.D.
Research and Development Senior Manager
Ph.D. – Product Marketing Manager